%0 Case Reports
%T Haemophagocytic lymphohistiocytosis after intravesical BCG administration for bladder cancer presenting with multiorgan failure.
%A Liatsos GD
%A Manousopoulou G
%A Poulaki A
%A Iliaki A
%A Mariolis I
%A Vassilopoulos D
%J Access Microbiol
%V 5
%N 9
%D 2023
%M 37841100
暂无%R 10.1099/acmi.0.000670.v3
%X Bacillus Calmette-Guérin (BCG), is administered intravesically as an adjuvant immunotherapy for the treatment of non-muscle invasive bladder cancer. While mild non-infectious problems can occur in up to 85 % of cases, significant local and systemic complications have been reported in 1-5 % of cases. We report the case of a patient with superficial bladder cancer who developed multiorgan failure after intravesical BCG instillation including the kidney and liver with subsequent haemophagocytic lymphohistiocytosis. Our case illustrates the first reported combination of secondary haemophagocytic lymphohistiocytosis with severe renal and liver failure after BCG immunotherapy for bladder carcinoma. Treatment strategy is discussed.